Gene · 1848
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mono(2-ethylhexyl) phthalate induces transcriptomic changes in placental cells based on concentration, fetal sex, and trophoblast cell type. | Arch Toxicol | 2023 | 36695872 | PubTator, text mining | PubMed |
| Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor. | Cancer Sci | 2023 | 36694355 | PubTator, text mining | PubMed |
| Differential co-expression network analysis with DCoNA reveals isomiR targeting aberrations in prostate cancer. | Bioinformatics | 2023 | 36688696 | PubTator, text mining | PubMed |
| Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies. | Int J Mol Sci | 2023 | 36675253 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36674513 | PubTator, text mining | PubMed |
| Gene-Function-Based Clusters Explore Intricate Networks of Gene Expression of Circulating Tumor Cells in Patients with Colorectal Cancer. | Biomedicines | 2023 | 36672653 | PubTator, text mining | PubMed |
| Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 36672453 | PubTator, text mining | PubMed |
| A rare disease of Kallmann syndrome: A case report. | Radiol Case Rep | 2023 | 36660569 | PubTator, text mining | PubMed |
| Annotation of uORFs in the OMIM genes allows to reveal pathogenic variants in 5'UTRs. | Nucleic Acids Res | 2023 | 36651276 | PubTator, text mining | PubMed |
| CIC reduces xCT/SLC7A11 expression and glutamate release in glioma. | Acta Neuropathol Commun | 2023 | 36647117 | PubTator, text mining | PubMed |
| Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. | Mol Cancer | 2023 | 36635659 | PubTator, text mining | PubMed |
| A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma. | Br J Cancer | 2023 | 36624219 | PubTator, text mining | PubMed |
| Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases. | Sci Rep | 2023 | 36624125 | PubTator, text mining | PubMed |
| NANOGP1, a tandem duplicate of NANOG, exhibits partial functional conservation in human naïve pluripotent stem cells. | Development | 2023 | 36621005 | PubTator, text mining | PubMed |
| Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications. | Lancet Diabetes Endocrinol | 2023 | 36620967 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer. | Cancers (Basel) | 2023 | 36612299 | PubTator, text mining | PubMed |
| Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis. | iScience | 2023 | 36594029 | PubTator, text mining | PubMed |
| Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. | Mol Oncol | 2023 | 36587394 | PubTator, text mining | PubMed |
| DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. | Nat Cancer | 2023 | 36581736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1848/papers?page=18